Apnimed Inc（APMD）财务数据APMDApnimed Inc

Evaluating the bottom line, Apnimed Inc maintains a gross margin of 89.98%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -96.89%, while the net margin is 1043.98%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively APMD converts its operational activities into shareholder value.

In the context of the broader market, APMD competes directly with industry leaders such as IVA and KURA. With a market capitalization of $770.59M, it holds a significant position in the sector. When comparing efficiency, APMD's gross margin of 89.98% stands against IVA's 100.00% and KURA's 98.84%. Such benchmarking helps identify whether Apnimed Inc is trading at a premium or discount relative to its financial performance.

Apnimed's financial performance has significantly improved, with Q2 2026 net income reaching $125.93 million, a stark contrast to the previous year's loss of $69.47 million. The gross margin has also increased to 89.98%, indicating strong profitability.